Atlas Trials

Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid Tumors

Clinical trial NCT02691780 · WITHDRAWN

Trial details

NCT number
NCT02691780
Sponsor
Samsung Medical Center
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Refractory Solid Tumors
Start date
2016-12-23
Primary completion
2018-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.